GO
Loading...

Novo Nordisk cuts diabetes drug timeline

Thursday, 7 Aug 2014 | 3:20 AM ET

Lars Rebien Sørensen, CEO of Novo Nordisk, says its diabetes drug Tresiba could come to the U.S. market at the start of 2016.